Amedisys Inc (AMED): Price and Financial Metrics


Amedisys Inc (AMED): $281.04

0.01 (+0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AMED Stock Summary

  • With a one year PEG ratio of 253.74, Amedisys Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 85.53% of US stocks.
  • Price to trailing twelve month operating cash flow for AMED is currently 31.95, higher than 83.8% of US stocks with positive operating cash flow.
  • The volatility of Amedisys Inc's share price is greater than that of merely 18.49% US stocks with at least 200 days of trading history.
  • Stocks that are quantitatively similar to AMED, based on their financial statements, market capitalization, and price volatility, are WOR, GTLS, TTEC, WD, and BKI.
  • Visit AMED's SEC page to see the company's official filings. To visit the company's web site, go to www.amedisys.com.

AMED Stock Price Chart Interactive Chart >

Price chart for AMED

AMED Price/Volume Stats

Current price $281.04 52-week high $325.12
Prev. close $281.03 52-week low $165.42
Day low $278.89 Volume 162,300
Day high $285.88 Avg. volume 196,643
50-day MA $273.58 Dividend yield N/A
200-day MA $256.78 Market Cap 9.23B

Amedisys Inc (AMED) Company Bio


Amedisys provides home health and hospice care services. It operates through two segments, Home Health and Hospice. The company was founded in 1982 and is based in Baton Rouge, Louisiana.

AMED Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$281.04$203.58 -28%

Below please find a table outlining a discounted cash flow forecast for AMED, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Amedisys Inc ranked in the 47th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 27.17%. As for the metrics that stood out in our discounted cash flow analysis of Amedisys Inc, consider:

  • The company's debt burden, as measured by earnings divided by interest payments, is 19.96 -- which is good for besting 79.88% of its peer stocks (US stocks in the Healthcare sector with positive cash flow).
  • The business' balance sheet reveals debt to be 3% of the company's capital (with equity being the remaining amount). Approximately only 13.59% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • AMED's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 3%; for context, that number is higher than 46.83% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-29%
1%-28%
2%-28%
3%-27%
4%-26%
5%-25%

For other companies in the Healthcare that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as AMED, try PRAH, ICLR, TMO, REGN, and STE.


AMED Latest News Stream


Event/Time News Detail
Loading, please wait...

AMED Latest Social Stream


Loading social stream, please wait...

View Full AMED Social Stream

Latest AMED News From Around the Web

Below are the latest news stories about Amedisys Inc that investors may wish to consider to help them evaluate AMED as an investment opportunity.

Community Health Systems Earnings May Display A Healthy Dose Of Upside

Photo by The Good Brigade/DigitalVision via Getty Images Introduction Community Health Systems (CYH) is the $1.48B general acute care operator offering a range of varied health care services across the United States. As one of the largest generalist healthcare set-ups, the venture's affiliates own, operate and lease 84 hospitals across...

Jacob Kilby on Seeking Alpha | April 16, 2021

Credit Suisse analyses the impact of CMS payment updates for FY22

Yesterday, the Centers for Medicare & Medicaid Services (“CMS”) issued proposed rules that would update the terms and policies for the Skilled Nursing Facility prospective payment system and Hospice base payments for fiscal 2022.Proposals include an increase of 2.3% of payments for hospices compared to the proposed 2.6% and the final 2.4% increase in...

Seeking Alpha | April 9, 2021

Biden Chips in $400B for Home Healthcare: Stocks to Watch

Biden's support to expand access to long-term care services under Medicaid bodes well for companies providing home healthcare.

Yahoo | April 1, 2021

Returns At Amedisys (NASDAQ:AMED) Are On The Way Up

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Firstly, we'd want to identify a...

Yahoo | April 1, 2021

Why Is Amedisys (AMED) Up 1.8% Since Last Earnings Report?

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yahoo | March 26, 2021

Read More 'AMED' Stories Here

AMED Price Returns

1-mo 3.95%
3-mo -7.22%
6-mo 11.92%
1-year 51.07%
3-year 320.47%
5-year 446.03%
YTD -4.19%
2020 75.73%
2019 42.53%
2018 122.18%
2017 23.65%
2016 8.42%

Continue Researching AMED

Here are a few links from around the web to help you further your research on Amedisys Inc's stock as an investment opportunity:

Amedisys Inc (AMED) Stock Price | Nasdaq
Amedisys Inc (AMED) Stock Quote, History and News - Yahoo Finance
Amedisys Inc (AMED) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.1321 seconds.